Comparison of real costs in the French healthcare system in newly diagnosed patients with pemphigus for first-line treatment with rituximab vs. standard corticosteroid regimen: data from a national multicentre trial

Comparison of real costs in the French healthcare system in newly diagnosed patients with pemphigus for first-line treatment with rituximab vs. standard corticosteroid regimen: data from a national multicentre trial. Hébert, V.; Vermeulin, T.; Tanguy, L.; Tedbirt, B.; Mignard, C.; Bénichou, J.; Joly, P.. The British Journal of Dermatology. 2019; : . doi:10.1111/bjd.18563
Article